Forced degradation of recombinant monoclonal antibodies: A practical guide

References

• Blessy M, Patel R, Prajapati P, Agrawal Y. Develpment of forced degradation and stability indicating studies of drugs- a review. J Pharm Anal. 2014;4(3):159-65. doi:10.1016/j.jpha.2013.09.003
   PubMedGoogle Scholar
• Hawe A, Wiggenhorn M, van de Weert M, Garbe JH, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812. PMID:22083792
   PubMed Web of Science ®Google Scholar
• Kilck S, Muijselaar P, Waterval J, Eichinger T, Korn C, Gerding T, Debets A, Sanger-van de Griend C, Van den Beld C, Somsen G., et al. Toward a generic approach for stress testing of drug substances and drug products. Pharm Technol. 2005, February, 48-66
   Google Scholar
• Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. doi:10.1007/s11095-009-0045-6. PMID:20143256
   PubMed Web of Science ®Google Scholar
• Tamizi E, Jouyban A. Forced degradation studies of biopharmaceuticals: Selection of stress conditions. Eur J Pharm Biopharm. 2016;98:26-46. doi:10.1016/j.ejpb.2015.10.016. PMID:26542454
   PubMed Web of Science ®Google Scholar
• Alexander AJ, Hughes DE Monitoring of IgG antibody thermal stability by micellar electrokinetic capillary chromatography and matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem. 1995;67(20):3626-32. doi:10.1021/ac00116a002. PMID:8644915
   PubMed Web of Science ®Google Scholar
• Andya JD, Maa YF, Costantino HR, Nguyen PA, Dasovich N, Sweeney TD, Hsu CC, Shire SJ. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm Res. 1999;16(3):350-58. doi:10.1023/A:1018805232453. PMID:10213364
   PubMed Web of Science ®Google Scholar
• Banks DD, Hambly DM, Scavezze JL, Siska CC, Stackhouse NL, Gadgil HS. The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studies. J Pharm Sci. 2009;98(12):4501-10. doi:10.1002/jps.21749. PMID:19388069
   PubMed Web of Science ®Google Scholar
• Fesinmeyer RM, Hogan S, Saluja A, Brych SR, Kras E, Narhi LO, Brems DN, Gokarn YR. Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies. Pharm Res. 2009;26(4):903-13. doi:10.1007/s11095-008-9792-z. PMID:19104916
   PubMed Web of Science ®Google Scholar
• Franey H, Brych SR, Kolvenbach CG, Rajan RS. Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates. Protein Sci. 2010;19(9):1601-15. doi:10.1002/pro.434. PMID:20556807
   PubMed Web of Science ®Google Scholar
• Hawe A, Kasper JC, Friess W, Jiskoot W. Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. Eur J Pharm Sci. 2009;38(2):79-87. doi:10.1016/j.ejps.2009.06.001. PMID:19540340
   PubMed Web of Science ®Google Scholar
• Jiskoot W, Beuvery EC, De Koning AA, Herron JN, Crommelin DJ. Analytical approaches to the study of monoclonal antibody stability. Pharm Res. 1990;7(12):1234-41.doi:10.1023/A:1015925519154. PMID:2095560
   PubMed Web of Science ®Google Scholar
• Joubert MK, Luo Q, Nashed-Samuel Y, Wypych J, Narhi LO. Classification and characterization of therapeutic antibody aggregates. J Biol Chem. 2011;286(28):25118-33. doi:10.1074/jbc.M110.160457. PMID:21454532
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Sun J. Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;837(1–2):35-43. doi:10.1016/j.jchromb.2006.03.053. PMID:16644295
   PubMed Web of Science ®Google Scholar
• Luo Q, Joubert MK, Stevenson R, Ketchem RR, Narhi LO, Wypych J Chemical modifications in therapeutic protein aggregates generated under different stress conditions. J Biol Chem. 2011;286(28):25134-44. doi:10.1074/jbc.M110.160440. PMID:21518762
   PubMed Web of Science ®Google Scholar
• Telikepalli SN, Kumru OS, Kalonia C, Esfandiary R, Joshi SB, Middaugh CR, Volkin D B. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions. J Pharm Sci. 2014;103(3):796-809. doi:10.1002/jps.23839. PMID:24452866
   PubMed Web of Science ®Google Scholar
• Van BN, Rehder D, Gadgil H, Matsumura M, Jacob J. Elucidation of two major aggregation pathways in an IgG2 antibody. J Pharm Sci. 2009;98(9):3013-30. doi:10.1002/jps.21514. PMID:18680168
   PubMed Web of Science ®Google Scholar
• Zhang A, Singh SK, Shirts MR, Kumar S, Fernandez EJ. Distinct aggregation mechanisms of monoclonal antibody under thermal and freeze-thaw stresses revealed by hydrogen exchange. Pharm Res. 2012;29(1):236-50. doi:10.1007/s11095-011-0538-y. PMID:21805212
   PubMed Web of Science ®Google Scholar
• Paborji M, Pochopin NL, Coppola WP, Bogardus JB Chemical and physical stability of chimeric L6, a mouse-human monoclonal antibody. Pharm Res. 1994;11(5):764-71. doi:10.1023/A:1018948901599. PMID:8058650
   PubMed Web of Science ®Google Scholar
• Cordoba AJ, Shyong BJ, Breen D, Harris RJ. Non-enzymatic hinge region fragmentation of antibodies in solution. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;818(2):115-21. doi:10.1016/j.jchromb.2004.12.033. PMID:15734150
   PubMed Web of Science ®Google Scholar
• Dillon TM, Bondarenko PV, Speed RM Development of an analytical reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry method for characterization of recombinant antibodies. J Chromatogr A 2004;1053(1–2):299-305. doi:10.1016/S0021-9673(04)01410-4. PMID:15543996
   PubMed Web of Science ®Google Scholar
• Dillon TM, Bondarenko PV, Rehder DS, Pipes GD, Kleemann GR, Ricci MS. Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. J Chromatogr A. 2006;1120(1–2):112-20. doi:10.1016/j.chroma.2006.01.016. PMID:16448656
   PubMed Web of Science ®Google Scholar
• Gaza-Bulseco G., Liu H. Fragmentation of a recombinant monoclonal antibody at various pH. Pharm Res. 2008;25(8):1881-90. doi:10.1007/s11095-008-9606-3. PMID:18473123
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Lundell E Assessment of antibody fragmentation by reversed-phase liquid chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;876(1):13-23. doi:10.1016/j.jchromb.2008.10.015. PMID:18993120
   PubMed Web of Science ®Google Scholar
• Xiang T, Lundell E, Sun Z, Liu H Structural effect of a recombinant monoclonal antibody on hinge region peptide bond hydrolysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;858(1–2):254-62. doi:10.1016/j.jchromb.2007.08.043. PMID:17901002
   PubMed Web of Science ®Google Scholar
• Smith MA, Easton M, Everett P, Lewis G, Payne M, Riveros-Moreno V, Allen G. Specific cleavage of immunoglobulin G by copper ions. Int J Pept Protein Res. 1996;48(1):48-55. doi:10.1111/j.1399-3011.1996.tb01105.x. PMID:8844262
   PubMedGoogle Scholar
• Ouellette D, Alessandri L, Piparia R, Aikhoje A, Chin A, Radziejewski C, Correia I. Elevated cleavage of human immunoglobulin gamma molecules containing a lambda light chain mediated by iron and histidine. Anal Biochem. 2009;389(2):107-17. doi:10.1016/j.ab.2009.03.027. PMID:19318085
   PubMed Web of Science ®Google Scholar
• Xiao G, Bondarenko PV. Identification and quantification of degradations in the Asp-Asp motifs of a recombinant monoclonal antibody. J. Pharm Biomed Anal. 2008;47(1):23-30. doi:10.1016/j.jpba.2007.11.050. PMID:18201853
   PubMed Web of Science ®Google Scholar
• Li W, Yang B, Zhou D, Xu J, Li W, Suen WC. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1048:121-29. doi:10.1016/j.jchromb.2017.02.019. PMID:28242491
   PubMed Web of Science ®Google Scholar
• Kroon DJ, Baldwin-Ferro A, Lalan P. Identification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping. Pharm. Res. 1992;9(11):1386-93. doi:10.1023/A:1015894409623. PMID:1475223
   PubMed Web of Science ®Google Scholar
• Yan B, Steen S, Hambly D, Valliere-Douglass J, Vanden Bos T, Smallwood S, Yates Z, Arroll T, Han Y, Gadgil H., et al. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. J Pharm Sci. 2009;98(10):3509-21. doi:10.1002/jps.21655. PMID:19475547
   PubMed Web of Science ®Google Scholar
• Zhang YT, Hu J, Pace AL, Wong R, Wang YJ, Kao YH. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;965:65-71. doi:10.1016/j.jchromb.2014.06.018. PMID:24999246
   PubMed Web of Science ®Google Scholar
• Lam XM, Yang JY, Cleland JL. Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J Pharm Sci. 1997;86(11):1250-55. doi:10.1021/js970143s. PMID:9383735
   PubMed Web of Science ®Google Scholar
• Chu GC, Chelius D, Xiao G, Khor HK, Coulibaly S, Bondarenko PV. Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures. Pharm Res. 2007;24(6):1145-56. doi:10.1007/s11095-007-9241-4. PMID:17385019
   PubMed Web of Science ®Google Scholar
• Huang HZ, Nichols A, Liu D Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestion. Anal Chem. 2009;81(4):1686-92. doi:10.1021/ac802708s. PMID:19146457
   PubMed Web of Science ®Google Scholar
• Yu XC, Joe K, Zhang Y, Adriano A, Wang Y, Gazzano-Santoro H, Keck RG, Deperalta G, Ling V. Accurate determination of succinimide degradation products using high fidelity trypsin digestion peptide map analysis. Anal Chem. 2011;83(15):5912-19. doi:10.1021/ac200750u. PMID:21692515
   PubMed Web of Science ®Google Scholar
• Valliere-Douglass J, Jones L, Shpektor D, Kodama P, Wallace A, Balland A, Bailey R, Zhang Y. Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry. Anal Chem. 2008;80(9):3168-74. doi:10.1021/ac702245c. PMID:18355059
   PubMed Web of Science ®Google Scholar
• Cacia J, Keck R, Presta LG, Frenz J. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. Biochemistry. 1996;35(6):1897-903. doi:10.1021/bi951526c. PMID:8639672
   PubMed Web of Science ®Google Scholar
• Kueltzo LA, Wang W, Randolph TW, Carpenter JF. Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing. J Pharm Sci. 2008;97(5):1801-12. doi:10.1002/jps.21110. PMID:17823949
   PubMed Web of Science ®Google Scholar
• Brych SR, Gokarn YR, Hultgen H, Stevenson RJ, Rajan R, Matsumura M. Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation. J Pharm Sci. 2010;99(2):764-81. doi:10.1002/jps.21868. PMID:19691118
   PubMed Web of Science ®Google Scholar
• Ghazvini S, Kalonia C, Volkin DB, Dhar P. Evaluating the role of the air-solution interface on the mechanism of subvisible particle formation caused by mechanical agitation for an IgG1 mAb. J Pharm Sci. 2016;105(5):1643-56. doi:10.1016/j.xphs.2016.02.027. PMID:27025981
   PubMed Web of Science ®Google Scholar
• Kiese S, Papppenberger A, Friess W, Mahler HC. Shaken, not stirred: mechanical stress testing of an IgG1 antibody. J Pharm Sci. 2008;97(10):4347-66. doi:10.1002/jps.21328. PMID:18240293
   PubMed Web of Science ®Google Scholar
• Mahler HC, Muller R, Friess W, Delille A, Matheus S. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. Eur J Pharm Biopharm. 2005;59(3):407-17. doi:10.1016/j.ejpb.2004.12.004. PMID:15760721
   PubMed Web of Science ®Google Scholar
• Serno T, Carpenter JF, Randolph TW, Winter G. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin. J Pharm Sci. 2010;99(3):1193-1206. doi:10.1002/jps.21931. PMID:19774651
   PubMed Web of Science ®Google Scholar
• Huh JH, White AJ, Brych SR, Franey H, Matsumura M. The identification of free cysteine residues within antibodies and a potential role for free cysteine residues in covalent aggregation because of agitation stress. J Pharm Sci. 2013;102(6):1701-11. doi:10.1002/jps.23505. PMID:23559428
   PubMed Web of Science ®Google Scholar
• Brady LJ, Martinez T, Balland A. Characterization of nonenzymatic glycation on a monoclonal antibody. Anal Chem. 2007;79(24):9403-13. doi:10.1021/ac7017469. PMID:17985928
   PubMed Web of Science ®Google Scholar
• Eppler A., Weigandt M., Hanefeld A., Bunjes H. Relevant shaking stress conditions for antibody preformulation development. Eur J Pharm Biopharm. 2010;74(2):139-47. doi:10.1016/j.ejpb.2009.11.005. PMID:19922795
   PubMed Web of Science ®Google Scholar
• Sharma DK, Oma P, Pollo MJ, Sukumar, M. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. J Pharm Sci. 2010;99(6):2628-42. doi:10.1002/jps.22046. PMID:20049937
   PubMed Web of Science ®Google Scholar
• Arosio P, Rima S, Morbidelli M. Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates. Pharm Res. 2013;30(3):641-54. doi:10.1007/s11095-012-0885-3. PMID:23054090
   PubMed Web of Science ®Google Scholar
• Cohen SL, Price C, Vlasak J. Beta-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage. J Am Chem Soc. 2007;129(22):6976-77. doi:10.1021/ja0705994. PMID:17500521
   PubMed Web of Science ®Google Scholar
• Nowak C, Ponniah G, Neill A, Liu H. Characterization of succinimide stability during trypsin digestion for LC-MS analysis. Anal Biochem. 2017;526:1-8. doi:10.1016/j.ab.2017.03.005. PMID:28274724
   PubMed Web of Science ®Google Scholar
• Liu YD, van Enk JZ, Flynn, GC. Human antibody Fc deamidation in vivo. Biologicals. 2009;37(5):313-22. doi:10.1016/j.biologicals.2009.06.001. PMID:19608432
   PubMed Web of Science ®Google Scholar
• Wang L, Amphlett G, Lambert JM, Blattler W, Zhang W. Structural characterization of a recombinant monoclonal antibody by electrospray time-of-flight mass spectrometry. Pharm Res. 2005;22(8):1338-49. doi:10.1007/s11095-005-5267-7. PMID:16078144
   PubMed Web of Science ®Google Scholar
• Chelius D, Rehder DS, Bondarenko PV. Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies. Anal Chem. 2005;77(18):6004-11. doi:10.1021/ac050672d. PMID:16159134
   PubMed Web of Science ®Google Scholar
• Sinha S, Zhang L, Duan S, Williams TD, Vlasak J, Ionescu R, Top, EM. Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody. Protein Sci. 2009;18(8):1573-84. doi:10.1002/pro.173. PMID:19544580
   PubMed Web of Science ®Google Scholar
• Huang L, Lu J, Wroblewski VJ, Beals JM, Riggin RM. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. Anal Chem. 2005;77(5):1432-39. doi:10.1021/ac0494174. PMID:15732928
   PubMed Web of Science ®Google Scholar
• Harris RJ, Kabakoff B, Macch FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl. 2001;752(2):233-45. doi:10.1016/S0378-4347(00)00548-X. PMID:11270864
   PubMed Web of Science ®Google Scholar
• Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corvaia N, Ionescu R, Beck A. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem. 2009;392(2):145-54. doi:10.1016/j.ab.2009.05.043. PMID:19497295
   PubMed Web of Science ®Google Scholar
• Creed D. The photophysics and photochemistry of the near-UV absorbing amino acids-I, Tryptophan and its simple derivatives. Photochem Photobiol. 1984;39(4):537-62. doi:10.1111/j.1751-1097.1984.tb03890.x
   Web of Science ®Google Scholar
• Holt LA, Milligan B, Rivett DE, Stewart FH. The photodecomposition of tryptophan peptides. Biochim Biophys Acta. 1977;499(1):131-38. doi:10.1016/0304-4165(77)90235-5. PMID:889893
   PubMed Web of Science ®Google Scholar
• Kerwin BA, Remmele RL, Jr. Protect from light: photodegradation and protein biologics. J Pharm Sci. 2007;96(6):1468-79. doi:10.1002/jps.20815. PMID:17230445
   PubMed Web of Science ®Google Scholar
• Singh SR, Zhang J, O'Dell C, Hsieh MC, Goldstein J, Liu J, Srivastava A. Effect of polysorbate 80 quality on photostability of a monoclonal antibody. AAPS PharmSciTech. 2012;13(2):422-30. doi:10.1208/s12249-012-9759-6. PMID:22362139
   PubMed Web of Science ®Google Scholar
• Qi P, Volkin DB, Zhao H, Nedved ML, Hughes R, Bass R, Yi SC, Panek ME, Wang D, Dalmonte P, et al. Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form. J Pharm Sci. 2009;98(9):3117-30. doi:10.1002/jps.21617. PMID:19009595
   PubMed Web of Science ®Google Scholar
• Nowak C, Ponniah G, Cheng G, Kita A, Neill A, Kori Y, Liu H. Liquid chromatography-fluorescence and liquid chromatography-mass spectrometry detection of tryptophan degradation products of a recombinant monoclonal antibody. Anal Biochem. 2016;496:4-8. doi:10.1016/j.ab.2015.12.004. PMID:26717898
   PubMed Web of Science ®Google Scholar
• Wei Z, Feng J., Lin HY, Mullapudi S, Bishop E, Tous GI, Casas-Finet J, Hakki F, Strouse R, Schenerman MA. Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. Anal Chem. 2007;79(7):2797-2805. doi:10.1021/ac062311j. PMID:17319649
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Zhou L. Mass spectrometry analysis of photo-induced methionine oxidation of a recombinant human monoclonal antibody. J Am Soc Mass Spectrom. 2009;20(3):525-28. doi:10.1016/j.jasms.2008.11.011. PMID:19103498
   PubMed Web of Science ®Google Scholar
• Li Y, Polozova A, Gruia F, Feng J. Characterization of the degradation products of a color-changed monoclonal antibody: tryptophan-derived chromophores. Anal Chem. 2014;86(14):6850-57. doi:10.1021/ac404218t. PMID:24937252
   PubMed Web of Science ®Google Scholar
• Reubsaet JL, Beijnen JH, Bult A, van Maanen RJ, Marchal JA, Underberg WJ. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. J Pharm Biomed Anal. 1998;17(6–7):955-78. doi:10.1016/S0731-7085(98)00063-6. PMID:9884187
   PubMed Web of Science ®Google Scholar
• Chumsae C, Gaza-Bulseco G, Sun J, Liu H. Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850(1–2):285-94. doi:10.1016/j.jchromb.2006.11.050. PMID:17182291
   PubMed Web of Science ®Google Scholar
• Valliere-Douglass JF, Connell-Crowley L, Jensen R, Schnier PD, Trilisky E, Leith M, Follstad B D, Kerr J, Lewis N, Vunnum S, et al. Photochemical degradation of citrate buffers leads to covalent acetonation of recombinant protein therapeutics. Protein Sci. 2010;19(11):2152-63. doi:10.1002/pro.495. PMID:20836085
   PubMed Web of Science ®Google Scholar
• Keck RG The use of t-butyl hydroperoxide as a probe for methionine oxidation in proteins. Anal Biochem. 1996;236(1):56-62. doi:10.1006/abio.1996.0131. PMID:8619496
   PubMed Web of Science ®Google Scholar
• Folzer E, Diepold K, Bomans K, Finkler C, Schmidt R, Bulau P, Huwyler J, Mahler HC, Koulov AV. Selective oxidation of methionine and tryptophan residues in a therapeutic igg1 molecule. J Pharm Sci. 2015;104(9):2824-31. doi:10.1002/jps.24509. PMID:26010344
   PubMed Web of Science ®Google Scholar
• Ma Y, Chao C, Stadtman ER. Oxidative modification of glutamine synthetase by 2,2′-Azobis(2-amidinopropane) dihydrochloride. Arch Biochem Biophys. 1999;363(1):129-34. doi:10.1006/abbi.1998.1076. PMID:10049507
   PubMed Web of Science ®Google Scholar
• Bertolotti-Ciarlet A, Wang W, Lownes R, Pristatsky P, Fang Y, McKelvey T, Li Y, Li Y, Drummond J, Prueksaritanont T, Vlasak J. Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. Mol Immunol. 2009;46(8–9):1878-82. doi:10.1016/j.molimm.2009.02.002. PMID:19269032
   PubMed Web of Science ®Google Scholar
• Pan H, Chen K, Chu L, Kinderman F, Apostol I, Huang G. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci. 2009;18(2):424-33. doi:10.1002/pro.45. PMID:19165723
   PubMed Web of Science ®Google Scholar
• Wang W, Vlasak J, Li Y, Pristatsky P, Fang Y, Pittman T, Roman J, Wang Y, Prueksaritanont T, Ionescu R. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. Mol Immunol. 2011;48(6–7):860-66. doi:10.1016/j.molimm.2010.12.009. PMID:21256596
   PubMed Web of Science ®Google Scholar
• Yang R, Jain T, Nobrega RP, Lu X, Boland T, Burnina I, Sun T, Caffry I, Brown M, Zhi X, et al. Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies. MAbs. 2017;9(4):646-53. doi:10.1080/19420862.2017.1290753
   PubMed Web of Science ®Google Scholar
• Liu D, Ren D, Huang H, Dankberg J, Rosenfeld R, Cocco MJ, Li L, Brems DN, Remmele RL, Jr. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. Biochemistry. 2008;47(18):5088-5100. doi:10.1021/bi702238b. PMID:18407665
   PubMed Web of Science ®Google Scholar
• Yan B, Yates Z, Balland A, Kleemann GR. Human IgG1 hinge fragmentation as the result of H2O2-mediated radical cleavage. J Biol Chem. 2009;284(51):35390-402. doi:10.1074/jbc.M109.064147. PMID:19850927
   PubMed Web of Science ®Google Scholar
• Goetze AM, Liu YD, Arroll T, Chu L, Flynn GC. Rates and impact of human antibody glycation in vivo. Glycobiology. 2012;22(2):221-34. doi:10.1093/glycob/cwr141. PMID:21930650
   PubMed Web of Science ®Google Scholar
• Gadgil HS, Bondarenko PV, Pipes G, Rehder D, McAuley A, Perico N, Dillon T, Ricci M, Treuheit M. The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. J Pharm Sci. 2007;96(10):2607-21. doi:10.1002/jps.20966. PMID:17621682
   PubMed Web of Science ®Google Scholar
• Quan C, Alcala E, Petkovska I, Matthews D, Canova-Davis E, Taticek R, Ma S. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior. Anal Biochem. 2008;373(2):179-91. doi:10.1016/j.ab.2007.09.027. PMID:18158144
   PubMed Web of Science ®Google Scholar
• Zhang B, Yang Y, Yuk I, Pai R, McKay P, Eigenbrot C, Dennis M, Katta V, Francissen K C. Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody. Anal Chem. 2008;80(7):2379-90. doi:10.1021/ac701810q. PMID:18307322
   PubMed Web of Science ®Google Scholar
• Butko M, Pallat H, Cordoba A, Yu XC Recombinant antibody color resulting from advanced glycation end product modifications. Anal Chem. 2014;86(19):9816-23. doi:10.1021/ac5024099. PMID:25181536
   PubMed Web of Science ®Google Scholar
• Miller AK, Hambly DM, Kerwin BA, Treuheit MJ, Gadgil HS. Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody. J Pharm Sci. 2011;100(7):2543-50. doi:10.1002/jps.22504. PMID:21287557
   PubMed Web of Science ®Google Scholar
• Yuk IH, Zhang B, Yang Y, Dutina G, Leach KD, Vijayasankaran N, Shen AY, Andersen DC, Snedecor BR, Joly JC. Controlling glycation of recombinant antibody in fed-batch cell cultures. Biotechnol Bioeng. 2011;108(11):2600-10. doi:10.1002/bit.23218. PMID:21618472
   PubMed Web of Science ®Google Scholar
• Fischer S, Hoernschemeyer J, Mahler H C. Glycation during storage and administration of monoclonal antibody formulations. Eur J Pharm. Biopharm. 2008;70(1):42-50. doi:10.1016/j.ejpb.2008.04.021. PMID:18583113
   PubMed Web of Science ®Google Scholar
• Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol. 2010;10(5):345-52. doi:10.1038/nri2747. PMID:20414207
   PubMed Web of Science ®Google Scholar
• Yang X, Xu W, Dukleska S, Benchaar S, Mengisen S, Antochshuk V, Cheung J, Mann L, Babadjanova Z, Rowand J, et al. Developability studies before initiation of process development: improving manufacturability of monoclonal antibodies. MAbs. 2013;5(5):787-94. doi:10.4161/mabs.25269. PMID:23883920
   PubMed Web of Science ®Google Scholar
• Jarasch A, Koll H, Regula JT, Bader M, Papadimitriou A, Kettenberger H. Developability assessment during the selection of novel therapeutic antibodies. J Pharm Sci. 2015;104(6):1885-98. doi:10.1002/jps.24430. PMID:25821140
   PubMed Web of Science ®Google Scholar
• Liu H, Ponniah G, Zhang HM, Nowak C, Neill A, Gonzalez-Lopez N, Patel R, Cheng G, Kita AZ, Andrien B. In vitro and in vivo modifications of recombinant and human IgG antibodies. MAbs. 2014;6(5):1145-54. doi:10.4161/mabs.29883. PMID:25517300
   PubMed Web of Science ®Google Scholar
• Rizzo JM, Shi S, Li Y, Semple A, Esposito JJ, Yu S, Richardson D, Antochshuk V, Shameem M. Application of a high-throughput relative chemical stability assay to screen therapeutic protein formulations by assessment of conformational stability and correlation to aggregation propensity. J Pharm Sci. 2015;104(5):1632-40. doi:10.1002/jps.24408. PMID:25757872
   PubMed Web of Science ®Google Scholar
• Wang T, Kumru OS, Yi L., Wang YJ., Zhang J., Kim JH., Joshi SB., Middaugh CR., Volkin D B. Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment. J Pharm Sci. 2013;102(8):2520-37. doi:10.1002/jps.23645. PMID:23824562
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J Pharm Sci. 2008;97(7):2426-47. doi:10.1002/jps.21180. PMID:17828757
   PubMed Web of Science ®Google Scholar
• Ponniah G, Kita A, Nowak C, Neill A, Kori Y, Rajendran S, Liu H. Characterization of the acidic species of a monoclonal antibody using weak cation exchange chromatography and LC-MS. Anal Chem. 2015;87(17):9084-92. doi:10.1021/acs.analchem.5b02385
   PubMed Web of Science ®Google Scholar
• Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, Beck H, Emrich T, Harris RJ. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44(5):291-305. doi:10.1016/j.biologicals.2016.06.005. PMID:27461239
   PubMed Web of Science ®Google Scholar
• Haberger M, Bomans K, Diepold K, Hook M, Gassner J, Schlothauer T, Zwick A, Spick C, Kepert JF, Hienz B, et al. Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes. MAbs. 2014;6(2):327-39. doi:10.4161/mabs.27876. PMID:24441081
   PubMed Web of Science ®Google Scholar
• Pisupati K, Benet A, Tian Y, Okbazghi S, Kang J, Ford M, Saveliev S, Sen KI, Carlson E, Tolbert TJ, et al. Biosimilarity under stress: a forced degradation study of Remicade® and Remsima™. MAbs. 2017;9(7): in press.
   PubMed Web of Science ®Google Scholar